Patients on TPO-RAs require regular monitoring to ensure efficacy and safety. Platelet counts are typically measured weekly until a stable count is achieved, followed by less frequent monitoring. Liver function tests are also conducted periodically to detect any signs of hepatotoxicity. Regular follow-ups are necessary to adjust dosages and to manage any adverse effects promptly.
